Compare PRG & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRG | OMCL |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Computer Manufacturing |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 2.1B |
| IPO Year | N/A | 2001 |
| Metric | PRG | OMCL |
|---|---|---|
| Price | $30.33 | $46.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | $37.50 | ★ $43.00 |
| AVG Volume (30 Days) | 633.1K | ★ 636.3K |
| Earning Date | 02-18-2026 | 02-05-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ 10.59 | N/A |
| EPS | ★ 3.96 | 0.43 |
| Revenue | ★ $2,507,179,000.00 | $1,177,740,000.00 |
| Revenue This Year | $1.24 | $8.61 |
| Revenue Next Year | $7.02 | $4.22 |
| P/E Ratio | ★ $7.70 | $109.07 |
| Revenue Growth | 3.71 | ★ 10.67 |
| 52 Week Low | $23.50 | $22.66 |
| 52 Week High | $44.43 | $47.69 |
| Indicator | PRG | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 70.61 |
| Support Level | $29.76 | $44.99 |
| Resistance Level | $30.58 | $46.56 |
| Average True Range (ATR) | 0.80 | 1.50 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 45.37 | 78.13 |
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.